PDC Line Pharma
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $35M
Investors
- 11
About PDC Line Pharma
Founded in 2014 by founder Laurent LEVY and based in La Tronche, France, PDC Line Pharma SAS developer of a class of off-the-shelf cancer immunotherapies using a proprietary technology called PDCline. PDCline Pharma's core technology is PDCline, a proprietary cell line of plasmacytoid dendritic cells (pDCs). These cells are designed to stimulate a strong immune response against cancer cells. The company product pipeline includes several cancer vaccine candidates: PDCmel for the treatment of melanoma. PDC Mel completed a Phase Ib trial to evaluate its safety and biological activity. PDC lung focused on non-small-cell lung cancer (NSCLC), targets widely expressed shared antigens, and a Phase Ib/II trial is underway to assess its safety and efficacy, both as a monotherapy and in combination with anti-PD-1 immune checkpoint inhibitors. PDC Neo is in the preclinical development stage and targets neoantigens, cancer-specific proteins.
Who invested in PDC Line Pharma
11 investors across 2 rounds
See all investors in PDC Line Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PDC Line Pharma
Who invested in PDC Line Pharma?
PDC Line Pharma has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PDC Line Pharma raised?
PDC Line Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PDC Line Pharma last raise money?
PDC Line Pharma's most recent round on record is a Series B, in Dec 2021.
What does PDC Line Pharma do?
Founded in 2014 by founder Laurent LEVY and based in La Tronche, France, PDC Line Pharma SAS developer of a class of off-the-shelf cancer immunotherapies using a proprietary technology called PDCline.
Where is PDC Line Pharma headquartered?
PDC Line Pharma is headquartered in France.
Which VCs invest in companies like PDC Line Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at PDC Line Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like PDC Line Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.